Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

June 15, 2007 (Vol. 27, No. 12)

Improving Drugs with Protein Engineering

How to Choose the Best Target, Optimize Delivery, and Reduce Immunogenicity

  • One challenge for protein engineers is to produce biopharmaceuticals that can withstand the proteolytic conditions of the gastrointestinal tract and serum. This was one of many challenges discussed at Cambridge Healthtech’s “PEGS Summit” held last month in Boston. To meet that demand, Manuel Vega, CEO of Nautilus Biotech (www.nautilusbiotech.com), ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.